10X Genomics

10X Genomics

World Rank (Jan-05-2024)
2,530
Market Cap (Jan-05-2024)
6.024 Billion USD
World Rank (Jul-30-2023)
2,165
Market Cap (Jul-30-2023)
7.310 Billion USD
World Rank (Jan-07-2022)
1,410
Market Cap (Jan-07-2022)
14.275 Billion USD
World Rank (Jan-01-2021)
1,171
Market Cap (Jan-01-2021)
15.237 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 753
Headquarters Country
USA
Nasdaq / NYSE Code
TXG
Market Cap (Mar-08-2026)
2.66
CEO
Serge Saxonov
Chairman
John R. Stuelpnagel, D.V.M
Employee Count
1,243
Employee Count as of Date
As on 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
516 Million USD
Annual Operating Income in USD
-167 Million USD
Annual Net Income in USD
-166 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,028 Million USD
Total Liabilities in USD
223 Million USD
Total Equity in USD
805 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Medical Equipment / Instruments
Healthcare Technology and Information
Company Website
10X GENOMICS
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

10x Genomics is a Biotechnology Industry and Healthcare company. It produces that combination of hardware, chemistry and software to give single cell and spatial views of biological systems. The company integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The headquarters is in USA.

Annual Results Summary

10X GENOMICS - Annual Result Summary - in Million USD

Year Ending:Total RevenueGross ProfitOperating IncomeNet Income
Dec-2022516396-167 (Loss)-166 (Loss)
Dec-2021490416-52 (Loss)-58 (Loss)
Dec-2020299240(534) (Loss)(543) (Loss)
Dec-2019246185(31) (Loss)(31) (Loss)
Dec-2018146118(111) (Loss)(112) (Loss)
Dec-20177161(18) (Loss)(19) (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,028 Million USD.

Total Liabilities as on Dec-2022 was 223 Million USD.

Total Equity as on Dec-2022 was 805 Million USD.

Founded Year
2012
IPO Year
2019
Stock Exchange
Nasdaq
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Industrials
Nasdaq Industry
Biotechnology: Laboratory Analytical Instruments

Share